In compliance with the JSE Limited Listings Requirements, shareholders are advised of the following dealings in Aspen’s securities by a third-party intermediary (“the Intermediary”).
A hedging transaction was entered into with the Intermediary to enable the Company to settle its future obligation to employees participating in the SA Management Deferred Incentive Bonus Scheme (“the Scheme”) of Aspen and three of its wholly owned South African subsidiaries, namely Pharmacare Limited, Aspen Finance (Pty) Limited and Fine Chemicals Corporation (Pty) Ltd. In terms of this hedging transaction the Intermediary acquired Aspen shares as follows:
Date of transaction:
26 November 2024
Nature and details of the transaction
On-market purchase of securities to satisfy the future